Laboratorios Leti, S.L.
25
0
0
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.0%
2 terminated/withdrawn out of 25 trials
92.0%
+5.5% vs industry average
16%
4 trials in Phase 3/4
0%
0 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract
Role: lead
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
Role: lead
Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma
Role: lead
Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract
Role: lead
Biological Standardization of Platanus Acerifolia Allergen Extract
Role: lead
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen
Role: lead
Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis
Role: collaborator
Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)
Role: lead
To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.
Role: lead
To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction.
Role: lead
Biological Standardization of Chenopodium Album Allergen Extract
Role: lead
Biological Potency of the Cat Epithelial Allergenic Extracts
Role: lead
Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).
Role: lead
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
Role: lead
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica
Role: lead
Biological Standardization of Blomia Tropicalis Allergen Extract
Role: lead
Biological Standardization of Lolium Perenne Allergen Extract
Role: lead
Biological Standardization of Poa Pratensis Allergen Extract
Role: lead
Biological Standardization of Secale Cereale Allergen Extract
Role: lead
Biological Standardization of Dactylis Glomerata Allergen Extract
Role: lead